Table 2.
Demographic, MOUD status, and retention information for the full sample, by treatment comparison group
| Pre-STR/SORa | STR/SORa | Non-STR/SORa | Combined | |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | |
| Sex | ||||
| Male | 661 (74%) | 1295 (76%) | 1029 (77%) | 2985 (76%) |
| Female | 227 (26%) | 406 (24%) | 300 (23%) | 933 (24%) |
| Race | ||||
| White | 500 (56%) | 1079 (63%) | 808 (61%) | 2387 (61%) |
| Black | 388 (44%) | 622 (37%) | 523 (39%) | 1533 (39%) |
| Received MOUD | 683 (77%) | 1508 (89%) | 866 (65%) | 3057 (78%) |
| M(SD) | M (SD) | M (SD) | M (SD) | |
| Age | 40.16 (9.43) | 39.15 (9.01) | 38.38 (9.37) | 39.12 (9.25) |
| Days in Treatment | 150.23 (169.17) | 213.51 (205.45) | 178.00 (185.93) | 187.12 (192.77) |
Note:
a
STR/SOR and Non-STR/SOR include FY18 and FY19, while Pre-STR/SOR includes FY17.